Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 80Neoplasm Metastasis 6Neoplasms 3Breast Neoplasms, Male 3Arthralgia 2Triple Negative Breast Neoplasms 1Sleep Wake Disorders 1Skin Diseases 1Prostatic Neoplasms 1Post Menopausal Women With Early Breast Cancer 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Obesity 1Metastatic Beast Cancer 1Mammary Neoplasms, Animal 1Lymphoma 1Lethal Congenital Contracture Syndrome 2 1Invasive Early Breast Cancer 1Human Epidermal Growth Factor 2 Negative Carcinoma of Breast 1Fatigue 1Estrogen-receptor Positive Invasive Metastatic Breast Cancer 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Diseases 1Breast Carcinoma In Situ 1Breast Cancer Metastatic 1Advanced Breast Carcinoma 1

Interventions

Tamoxifen 9Letrozole 5Anastrozole 5Radiotherapy 3Radiation 3Neoadjuvant Therapy 3afimoxifene 2Trastuzumab 2Surgical Procedures, Operative 2Simvastatin 2Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Mastectomy, Segmental 2Lapatinib 2Gene Expression Profiling 2trastuzumab biosimilar HLX02 1telapristone acetate 1sargramostim 1polyphenon E 1pasireotide 1palbociclib 1oxybutynin 1liposomal doxorubicin 1exemestane 1Zoledronic Acid 1UAB 30 1Tea 1Sugars 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Intraductal, Noninfiltrating × exemestane × Clear all
NCT01272037 2026-06-03

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
5,018 enrolled 14 charts
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡